RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+139.82%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$3.3B
AUM Growth
+$3.3B
Cap. Flow
+$632M
Cap. Flow %
19.16%
Top 10 Hldgs %
71.48%
Holding
41
New
9
Increased
7
Reduced
2
Closed
7

Top Buys

1
CCXI
ChemoCentryx, Inc.
CCXI
$127M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
$114M
3
ETNB icon
89bio
ETNB
$83.1M
4
ARVN icon
Arvinas
ARVN
$82.6M
5
FTSV
Forty Seven, Inc. Common Stock
FTSV
$76.1M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$35.3M
2
MYOV
Myovant Sciences Ltd.
MYOV
$32.1M
3
AXSM icon
Axsome Therapeutics
AXSM
$30.7M
4
DTIL icon
Precision BioSciences
DTIL
$15.5M
5
KOD icon
Kodiak Sciences
KOD
$14.7M

Sector Composition

1 Healthcare 95.85%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
THOR
1
DELISTED
Synthorx, Inc. Common Stock
THOR
$680M 20.61%
9,724,598
– –
ASND icon
2
Ascendis Pharma
ASND
$12.1B
$582M 17.66%
4,185,342
+52,900
+1% +$7.36M
RARX
3
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$228M 6.91%
4,858,260
– –
ARVN icon
4
Arvinas
ARVN
$580M
$151M 4.58%
3,672,872
+2,009,360
+121% +$82.6M
CCXI
5
DELISTED
ChemoCentryx, Inc.
CCXI
$127M 3.84%
+3,199,389
New +$127M
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$6.92B
$124M 3.78%
5,422,312
+2,000,000
+58% +$45.9M
EIDX
7
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$124M 3.76%
2,162,671
– –
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
$118M 3.57%
2,260,751
– –
PHAT icon
9
Phathom Pharmaceuticals
PHAT
$841M
$114M 3.44%
+3,646,808
New +$114M
TGTX icon
10
TG Therapeutics
TGTX
$4.72B
$110M 3.33%
9,880,323
+3,000,000
+44% +$33.3M
STSA
11
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$92.1M 2.79%
4,681,858
– –
ORTX
12
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$87.9M 2.66%
6,389,901
+1,165,426
+22% +$16M
ETNB icon
13
89bio
ETNB
$1.36B
$83.1M 2.52%
+3,161,214
New +$83.1M
FTSV
14
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$76.1M 2.31%
+1,933,250
New +$76.1M
WVE icon
15
Wave Life Sciences
WVE
$1.53B
$62.3M 1.89%
7,775,207
– –
TVTX icon
16
Travere Therapeutics
TVTX
$1.62B
$60.4M 1.83%
4,252,453
+264,893
+7% +$3.76M
BOLD
17
DELISTED
Audentes Therapeutics, Inc
BOLD
$54M 1.64%
+902,383
New +$54M
PRVL
18
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$53.2M 1.61%
3,363,605
– –
CRNX icon
19
Crinetics Pharmaceuticals
CRNX
$3.14B
$47M 1.43%
1,875,209
– –
ARDX icon
20
Ardelyx
ARDX
$1.54B
$40.2M 1.22%
+5,358,863
New +$40.2M
AXSM icon
21
Axsome Therapeutics
AXSM
$6.16B
$38M 1.15%
367,816
-296,569
-45% -$30.7M
IGMS
22
DELISTED
IGM Biosciences
IGMS
$37.5M 1.14%
982,723
+516,355
+111% +$19.7M
STOK icon
23
Stoke Therapeutics
STOK
$1.07B
$31.7M 0.96%
1,119,963
– –
RLMD icon
24
Relmada Therapeutics
RLMD
$47.1M
$29.7M 0.9%
+761,666
New +$29.7M
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$28.5M 0.87%
+1,445,801
New +$28.5M
1
2